Blue Earth Diagnostics Announces Axumin (Fluciclovine F 18) Presentations at Upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today highlighted presentations at the 2021 American Society
Source: finanznachrichten.de